StemSave Blog

Researchers at the University Hospital Niño Jesus in Madrid, Spain, are conducting a clinical trial to determine the safety and efficacy of treating cerebral palsy patients with hematopoietic stem cells from cord blood, as well as mesenchymal stem cells [MSCs] from umbilical cord tissue. The scientists will compare the two types of autologous [the patient’s own] stem cells in their effectiveness regarding immune-regulation, anti-inflammatory activity, and stimulation of brain tissue regeneration.